Agamasu Constance, Frank Peter, Perkins Shelley, Waybright Timothy, Messing Simon, Gillette William, Stephen Andrew G
NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research.
NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research;
J Vis Exp. 2020 Jan 16(155). doi: 10.3791/60703.
Protein prenylation is a key modification that is responsible for targeting proteins to intracellular membranes. KRAS4b, which is mutated in 22% of human cancers, is processed by farnesylation and carboxymethylation due to the presence of a 'CAAX' box motif at the C-terminus. An engineered baculovirus system was used to express farnesylated and carboxymethylated KRAS4b in insect cells and has been described previously. Here, we describe the detailed, practical purification and biochemical characterization of the protein. Specifically, affinity and ion exchange chromatography were used to purify the protein to homogeneity. Intact and native mass spectrometry was used to validate the correct modification of KRAS4b and to verify nucleotide binding. Finally, membrane association of farnesylated and carboxymethylated KRAS4b to liposomes was measured using surface plasmon resonance spectroscopy.
蛋白质异戊二烯化是一种关键修饰,负责将蛋白质靶向细胞内膜。KRAS4b在22%的人类癌症中发生突变,由于其C末端存在“CAAX”盒基序,可通过法尼基化和羧甲基化进行加工。一种工程化杆状病毒系统被用于在昆虫细胞中表达法尼基化和羧甲基化的KRAS4b,此前已有相关描述。在此,我们描述了该蛋白质详细、实用的纯化方法及生化特性。具体而言,采用亲和色谱和离子交换色谱将蛋白质纯化至同质。利用完整和天然质谱法验证KRAS4b的正确修饰并验证核苷酸结合。最后,使用表面等离子体共振光谱法测量法尼基化和羧甲基化的KRAS4b与脂质体的膜结合。